Corbus Pharmaceuticals Holdings, Inc. (CRBP) Form 8-K — Jul 6, 2026
Corbus Pharmaceuticals appointed Leonardo Viana Nicacio, MD as Chief Medical Officer effective August 3, 2026, bringing over 20 years of experience in oncology drug development and commercialization. Dr. Nicacio’s employment agreement includes an annual base salary of $545,000 and a target annual bonus of up to 40% of his base salary.
Key figures
- Term Years
- 2
- Base Salary
- 545000
- Target Bonus Percent
- 40
- Inducement Equity Value
- 2100000
Price after filing
1 day: +4.2%7 days: +0.4%30 days: +4.4%
Close on the filing date to close N calendar days later (from $9.00). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.